Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 3
2010 3
2011 4
2012 1
2014 2
2015 1
2016 2
2017 2
2018 4
2019 2
2020 5
2021 2
2022 4
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and treatment of cytomegalovirus 2013.
Einsele H, Mielke S, Grigoleit GU. Einsele H, et al. Among authors: grigoleit gu. Curr Opin Hematol. 2014 Nov;21(6):470-5. doi: 10.1097/MOH.0000000000000090. Curr Opin Hematol. 2014. PMID: 25295744 Review.
CMV-specific T cell therapy.
Einsele H, Kapp M, Grigoleit GU. Einsele H, et al. Among authors: grigoleit gu. Blood Cells Mol Dis. 2008 Jan-Feb;40(1):71-5. doi: 10.1016/j.bcmd.2007.07.002. Epub 2007 Sep 11. Blood Cells Mol Dis. 2008. PMID: 17851094 Review.
Adoptive immunotherapy with virus-specific T cells.
Fuji S, Kapp M, Grigoleit GU, Einsele H. Fuji S, et al. Among authors: grigoleit gu. Best Pract Res Clin Haematol. 2011 Sep;24(3):413-9. doi: 10.1016/j.beha.2011.06.003. Best Pract Res Clin Haematol. 2011. PMID: 21925094 Review.
Impaired T and "memory-like" NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation.
Lauruschkat CD, Muchsin I, Rein AF, Erhard F, Grathwohl D, Dölken L, Köchel C, Nehmer A, Falk CS, Grigoleit GU, Einsele H, Wurster S, Kraus S. Lauruschkat CD, et al. Among authors: grigoleit gu. Blood Adv. 2024 Feb 5:bloodadvances.2023012008. doi: 10.1182/bloodadvances.2023012008. Online ahead of print. Blood Adv. 2024. PMID: 38315873
Peptide Receptor Radionuclide Therapy for Sarcoidosis.
Lapa C, Grigoleit GU, Hänscheid H, Klinker E, Jung P, Herrmann K, Schirbel A, Böck M, Buck AK, Pelzer T. Lapa C, et al. Among authors: grigoleit gu. Am J Respir Crit Care Med. 2016 Dec 1;194(11):1428-1430. doi: 10.1164/rccm.201603-0579LE. Am J Respir Crit Care Med. 2016. PMID: 27905851 No abstract available.
Cellular therapy to control tumor progression.
Kapp M, Rasche L, Einsele H, Grigoleit GU. Kapp M, et al. Among authors: grigoleit gu. Curr Opin Hematol. 2009 Nov;16(6):437-43. doi: 10.1097/MOH.0b013e32832f57d4. Curr Opin Hematol. 2009. PMID: 19587587 Review.
37 results